Expand CLDI Menu
CLDI MENU

CLDI Latest Press Releases

-- March 12, 2026 --

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing Globe Newswire 8:00 AM

-- March 9, 2026 --

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option Globe Newswire 8:50 PM

-- March 6, 2026 --

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering Globe Newswire 8:30 AM

-- March 5, 2026 --

Calidi Biotherapeutics Announces Proposed Public Offering Globe Newswire 5:57 PM

-- February 20, 2026 --

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference Globe Newswire 8:00 AM

-- February 12, 2026 --

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference Globe Newswire 8:00 AM

-- January 28, 2026 --

Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026 Globe Newswire 8:00 AM

-- November 17, 2025 --

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025 Globe Newswire 8:00 AM

-- November 13, 2025 --

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights Globe Newswire 4:15 PM

-- November 10, 2025 --

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC Globe Newswire 8:00 AM

-- November 4, 2025 --

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting Globe Newswire 8:00 AM

-- November 3, 2025 --

Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND PRNewswire 8:00 AM

-- October 30, 2025 --

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting Globe Newswire 8:00 AM

-- October 22, 2025 --

Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes